ANDREW MURPHY - 08 Dec 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Andrew Murphy
Issuer symbol
REGN
Transactions as of
08 Dec 2021
Transactions value $
-$10,049,085
Form type
4
Filing time
10 Dec 2021, 17:42:09 UTC
Previous filing
17 Nov 2021
Next filing
14 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +3,462 +6.2% $0 59,167 08 Dec 2021 Direct F1
transaction REGN Common Stock Options Exercise $858,495 +16,500 +28% $52.03* 75,667 09 Dec 2021 Direct F2
transaction REGN Common Stock Tax liability -$6,162,377 -9,378 -12% $657.11 66,289 09 Dec 2021 Direct F2
transaction REGN Common Stock Sale -$262,386 -399 -0.6% $657.61 65,890 10 Dec 2021 Direct F2, F3
transaction REGN Common Stock Sale -$217,397 -330 -0.5% $658.78 65,560 10 Dec 2021 Direct F2, F4
transaction REGN Common Stock Sale -$243,937 -370 -0.56% $659.29 65,190 10 Dec 2021 Direct F2, F5
transaction REGN Common Stock Sale -$2,641 -4 -0.01% $660.45 65,186 10 Dec 2021 Direct F2, F6
transaction REGN Common Stock Sale -$186,562 -282 -0.43% $661.57 64,904 10 Dec 2021 Direct F2, F7
transaction REGN Common Stock Sale -$234,475 -354 -0.55% $662.36 64,550 10 Dec 2021 Direct F2, F8
transaction REGN Common Stock Sale -$180,501 -272 -0.42% $663.61 64,278 10 Dec 2021 Direct F2, F9
transaction REGN Common Stock Sale -$104,956 -158 -0.25% $664.28 64,120 10 Dec 2021 Direct F2, F10
transaction REGN Common Stock Sale -$268,777 -404 -0.63% $665.29 63,716 10 Dec 2021 Direct F2, F11
transaction REGN Common Stock Sale -$255,897 -384 -0.6% $666.4 63,332 10 Dec 2021 Direct F2, F12
transaction REGN Common Stock Sale -$186,900 -280 -0.44% $667.5 63,052 10 Dec 2021 Direct F2, F13
transaction REGN Common Stock Sale -$1,161,713 -1,738 -2.8% $668.42 61,314 10 Dec 2021 Direct F2, F14
transaction REGN Common Stock Sale -$681,652 -1,018 -1.7% $669.6 60,296 10 Dec 2021 Direct F2, F15
transaction REGN Common Stock Sale -$584,832 -872 -1.4% $670.68 59,424 10 Dec 2021 Direct F2, F16
transaction REGN Common Stock Sale -$147,021 -219 -0.37% $671.33 59,205 10 Dec 2021 Direct F2, F17
transaction REGN Common Stock Sale -$25,547 -38 -0.06% $672.3 59,167 10 Dec 2021 Direct F2
holding REGN Common Stock 4,269 08 Dec 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -16,500 -100% $0* 0 09 Dec 2021 Common Stock 16,500 $52.03 Direct F2, F18
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +14,783 $0 14,783 08 Dec 2021 Common Stock 14,783 $644.54 Direct F18
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
F2 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F3 Represents volume-weighted average price of sales of 399 shares of Company stock on December 10, 2021 at prices ranging from $657.27 to $657.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 330 shares of Company stock on December 10, 2021 at prices ranging from $658.02 to $658.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 370 shares of Company stock on December 10, 2021 at prices ranging from $659.29 to $659.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $660.38 to $660.47. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 282 shares of Company stock on December 10, 2021 at prices ranging from $661.27 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 354 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 272 shares of Company stock on December 10, 2021 at prices ranging from $663.14 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 158 shares of Company stock on December 10, 2021 at prices ranging from $664.06 to $664.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F11 Represents volume-weighted average price of sales of 404 shares of Company stock on December 10, 2021 at prices ranging from $665.03 to $665.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F12 Represents volume-weighted average price of sales of 384 shares of Company stock on December 10, 2021 at prices ranging from $666.06 to $666.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F13 Represents volume-weighted average price of sales of 280 shares of Company stock on December 10, 2021 at prices ranging from $667.01 to $667.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F14 Represents volume-weighted average price of sales of 1,738 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F15 Represents volume-weighted average price of sales of 1,018 shares of Company stock on December 10, 2021 at prices ranging from $669.03 to $669.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F16 Represents volume-weighted average price of sales of 872 shares of Company stock on December 10, 2021 at prices ranging from $670.11 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F17 Represents volume-weighted average price of sales of 219 shares of Company stock on December 10, 2021 at prices ranging from $671.19 to $671.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F18 The stock option award vests in four equal annual installments, commencing one year after the date of grant.